- Home
- CTNM vs ILPT Comparison
CTNM vs ILPT Comparison
Compare CTNM & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNM | ILPT |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.4M | 540.0M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CTNM | ILPT |
|---|---|---|
| Price | $11.94 | $8.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $19.00 | $7.05 |
| AVG Volume (30 Days) | 197.5K | ★ 451.5K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | 0.46 | ★ 31.51 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.04 |
| Revenue Next Year | N/A | $2.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.72 | $4.50 |
| 52 Week High | $16.33 | $9.17 |
Technical Indicators
Market Signals| Indicator | CTNM | ILPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 43.98 |
| Support Level | $11.82 | $5.10 |
| Resistance Level | $13.40 | $8.25 |
| Average True Range (ATR) | 0.93 | 0.33 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 32.56 | 3.17 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.